| Literature DB >> 29625051 |
Tathiane M Malta1, Artem Sokolov2, Andrew J Gentles3, Tomasz Burzykowski4, Laila Poisson5, John N Weinstein6, Bożena Kamińska7, Joerg Huelsken8, Larsson Omberg9, Olivier Gevaert3, Antonio Colaprico10, Patrycja Czerwińska11, Sylwia Mazurek12, Lopa Mishra13, Holger Heyn14, Alex Krasnitz15, Andrew K Godwin16, Alexander J Lazar6, Joshua M Stuart17, Katherine A Hoadley18, Peter W Laird19, Houtan Noushmehr20, Maciej Wiznerowicz21.
Abstract
Cancer progression involves the gradual loss of a differentiated phenotype and acquisition of progenitor and stem-cell-like features. Here, we provide novel stemness indices for assessing the degree of oncogenic dedifferentiation. We used an innovative one-class logistic regression (OCLR) machine-learning algorithm to extract transcriptomic and epigenetic feature sets derived from non-transformed pluripotent stem cells and their differentiated progeny. Using OCLR, we were able to identify previously undiscovered biological mechanisms associated with the dedifferentiated oncogenic state. Analyses of the tumor microenvironment revealed unanticipated correlation of cancer stemness with immune checkpoint expression and infiltrating immune cells. We found that the dedifferentiated oncogenic phenotype was generally most prominent in metastatic tumors. Application of our stemness indices to single-cell data revealed patterns of intra-tumor molecular heterogeneity. Finally, the indices allowed for the identification of novel targets and possible targeted therapies aimed at tumor differentiation.Entities:
Keywords: The Cancer Genome Atlas; cancer stem cells; dedifferentiation; epigenomic; genomic; machine learning; pan-cancer; stemness
Mesh:
Substances:
Year: 2018 PMID: 29625051 PMCID: PMC5902191 DOI: 10.1016/j.cell.2018.03.034
Source DB: PubMed Journal: Cell ISSN: 0092-8674 Impact factor: 41.582